Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALPN

Alpine Immune Sciences (ALPN) Stock Price, News & Analysis

Alpine Immune Sciences logo

About Alpine Immune Sciences Stock (NASDAQ:ALPN)

Advanced Chart

Key Stats

Today's Range
$64.97
$64.97
50-Day Range
$64.37
$64.97
52-Week Range
$8.33
$65.00
Volume
2 shs
Average Volume
1.92 million shs
Market Capitalization
$4.46 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALPN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpine Immune Sciences and its competitors with MarketBeat's FREE daily newsletter.

ALPN Stock News Headlines

Alpine Immune Sciences Inc.
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
What 11 Analyst Ratings Have To Say About Alpine Immune Sciences
Alpine Immune Sciences Inc
See More Headlines

ALPN Stock Analysis - Frequently Asked Questions

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) announced its quarterly earnings data on Tuesday, November, 9th. The biotechnology company reported ($0.55) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.56. The biotechnology company earned $8.52 million during the quarter, compared to the consensus estimate of $22.30 million. Alpine Immune Sciences had a negative trailing twelve-month return on equity of 14.86% and a negative net margin of 65.17%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alpine Immune Sciences investors own include NVIDIA (NVDA), Broadcom (AVGO), e.l.f. Beauty (ELF), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL) and Novo Nordisk A/S (NVO).

Company Calendar

Last Earnings
11/09/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ALPN
CIK
1626199
Employees
142
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.18 million
Net Margins
-65.17%
Pretax Margin
-64.99%
Return on Equity
-14.86%
Return on Assets
-11.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.56
Quick Ratio
9.56

Sales & Book Value

Annual Sales
$56.52 million
Price / Sales
78.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.85 per share
Price / Book
13.40

Miscellaneous

Outstanding Shares
68,598,000
Free Float
39,581,000
Market Cap
$4.46 billion
Optionable
Optionable
Beta
0.97
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:ALPN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners